Bioorganic and Medicinal Chemistry Letters p. 3661 - 3666 (2008)
Update date:2022-08-03
Topics:
Koryakova, Angela G.
Ivanenkov, Yan A.
Ryzhova, Elena A.
Bulanova, Elena A.
Karapetian, Ruben N.
Mikitas, Olga V.
Katrukha, Eugeny A.
Kazey, Vasily I.
Okun, Ilya
Kravchenko, Dmitry V.
Lavrovsky, Yan V.
Korzinov, Oleg M.
Ivachtchenko, Alexandre V.
Synthesis, biological evaluation, and SAR dependencies for a series of novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamide inhibitors of GSK-3β kinase are described. The inhibitory activity of the synthesized compounds is highly dependent on the character of substituents in the phenyl ring and the nature of terminal heterocyclic fragment of the core molecular scaffold. The most potent compounds from this series contain 3,4-di-methyl or 2-methoxy substituents within the phenyl ring and 3-pyridine fragment connected to the 1,2,4-oxadiazole heterocycle. These compounds selectively inhibit GSK-3β kinase with IC50 value of 0.35 and 0.41 μM, respectively.
View MoreShanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Shanghai Rich Chemicals Co., Ltd
website:http://www.richchemical.com
Contact:+86-21-20255798
Address:Pudong Shanghai,China
WUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Shifang Taifeng New Flame Retardant Co., Ltd
Contact:02884721008
Address:tingjiang industrial park, hefeng town
Doi:10.1021/jo00357a012
(1986)Doi:10.1002/anie.202104975
(2021)Doi:10.1002/adsc.201200960
(2013)Doi:10.1021/acs.oprd.6b00382
(2017)Doi:10.1080/10426500601047438
(2007)Doi:10.1016/j.poly.2006.11.024
(2007)